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To investigate the mechanisms underlying the expression
of allergic contact dermatitis, we compared the
characteristics of nickel (Ni)-specific T cell responses in
10 patients with allergic contact dermatitis to Ni and in
10 healthy, nonallergic individuals. CD4F T cells purified
from peripheral blood of both allergic and nonallergic
subjects proliferated similarly to NiSO4 in vitro, with the
responses mostly restricted to CD4F CD45ROF memory
T cells. In contrast, Ni-specific CD8F T cell responses
were detected only in allergic patients. Limiting dilution
assay confirmed a high frequency of Ni-specific CD4F T
cells in both individual categories, and of Ni-specific
CD8F T cells in allergic patients, but not in nonallergic
persons. Ni-specific CD4F T cell clones prepared from
nonallergic subjects displayed lower interferon-g and
Allergic contact dermatitis (ACD) is the result of a T cellmediated immune response to haptens applied onto theskin (Grabbe and Schwarz, 1998). Haptens are highlyreactive, lipophilic small chemicals that acquire immuno-genicity by coupling to peptides loaded on major histo-
compatibility complex (MHC) molecules (Martin et al, 1992; Cavani
et al, 1995). Haptens penetrating the skin are picked up by dendritic
cells, which then migrate to regional lymph nodes where the hapten-
peptide complexes are presented in a MHC-restricted fashion to
specific naı¨ve T cells (Cruz et al, 1989; Hauser, 1990; Girolomoni et al,
1993; Bacci et al, 1997). Cutaneous challenge of sensitized subjects
with the relevant hapten causes a rapid recruitment and expansion of
hapten-specific T cells into the skin, and gives rise to the inflammatory
reaction. Skin homing of T lymphocytes is mainly regulated through
the expression of the cutaneous lymphocyte-associated antigen (CLA),
a highly sialylated adhesion molecule that binds to E-selectin on
activated endothelium (Picker et al, 1991; Santamaria Babi et al, 1995;
Fuhlbrigge et al, 1997). In murine models, evidence exists that cytokines
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higher interleukin-10 production compared with T cell
clones from allergic patients. The T cell skin-homing
receptor, cutaneous lymphocyte-associated antigen, was
expressed on the large majority of specific CD4F clones
from both the groups. Finally, Ni-specific CD8F clones
prepared from patients also expressed the cutaneous
lymphocyte-associated antigen receptor, and released
high interferon-g and no interleukin-4. In aggregate, the
results suggest that the presence of specific CD8F T
cells and a distinct pattern of cytokine release (e.g., an
augmented production of interleukin-10) by CD4F T
cells can be important elements in determining whether
a hapten induces allergy or a silent immune response.
Key words: allergy/cytokines/skin/T lymphocytes. J Invest
Dermatol 111:621–628, 1998
have a profound influence on contact hypersensitivity (CH) to haptens,
which is promoted by interleukin (IL)-12 and type 1 cytokines (Muller
et al, 1995; Riemann et al, 1996), and downregulated by IL-10, and
to a lesser extent by IL-4 (Gautam et al, 1992; Enk et al, 1994; Ferguson
et al, 1994; Berg et al, 1995; Asada et al, 1997). Additionally, it has
been suggested that the magnitude of murine CH depends upon the
balance between hapten-specific CD81 T cells, playing primarily an
effector role, and CD41 T lymphocytes, including IL-10 and IL-4
producing subsets, with prominent regulatory functions (Gocinski and
Tigelaar, 1990; Bour et al, 1995; Xu et al, 1996).
In humans, whether ACD expression could be regulated through
the activity of Th1/Th2 or CD41/CD81 T cell subsets is largely
unknown. In particular, ACD to nickel (Ni) has been linked to the
presence of specific CD41 T cells belonging to the Th1 subset, which
can be isolated from both peripheral blood and the site of cutaneous
challenge (patch test) of allergic patients (Sinigaglia et al, 1985;
Kapsenberg et al, 1987, 1992). More recently, however, Ni-specific
Th2 cell clones have been isolated from the skin of patients (Werfel
et al, 1997). In nonallergic individuals, Ni-specific T cell responses
have been described as well (von Blomberg-van der Fliers et al,
1987), although most of the authors interpreted such responses as the
consequence of a nonspecific mitogenic effect of the metal on T cells
(Pappas et al, 1970; Svejgaard et al, 1978; Ra¨sa¨nen and Tuomi, 1992).
Instead, these findings may suggest that nonallergic subjects can mount
immune responses to Ni, and that regulatory mechanisms may prevent
disease expression. Therefore, in this study we compared the character-
istics of Ni-specific T cell responses in patients with ACD and in
healthy, nonallergic individuals. Our results appear to indicate that
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CD81 T cells are crucial for the expression of ACD to Ni, because
Ni-specific CD81 T cell responses were detected in patients with
ACD to Ni, but not in nonallergic individuals. In contrast, both subject
categories harbor strong memory CD41 T cell responses to Ni, with
Ni-specific CD41 CLA1 T cell clones from nonallergic individuals
producing higher amounts of IL-10 and lower interferon (IFN)-γ.
Thus, distinct mechanisms may contribute to maintain clinically silent
ongoing T cell immune responses to Ni.
MATERIALS AND METHODS
Patients and nonallergic individuals Ten nonatopic patients (median age,
31 y; nine females and one male) with ACD to Ni and 10 nonatopic, age-
matched healthy volunteers (median age, 30 y; six females and four males)
without history of cutaneous allergy to metals were included in the study. Both
patients with ACD to metals and control subjects were tested with a standard
patch test series, including NiSO4 5% in petrolatum (International Contact
Dermatitis Research Group Series). Patch tests were applied under occlusion
with Finn Chambers (Alpharma, Norgesplaster, Norway) on the upper back,
and evaluated after 48 and 72 h. The reactivity was graded as follows: –, no
reaction; 1, redness, edema; 11, redness, edema, and papules; 111, redness,
papules, and vesicles. To increase patch test sensitivity and definitively exclude
contact sensitivity to the metal, healthy controls were also selected on the basis
of a negative patch test to 5% NiSO4 performed after 24 h pretreatment of the
skin with 0.1% sodium lauryl sulfate (Seidenari et al, 1996). Both patients and
controls were not taking any medication for at least 15 d before blood donation.
Peripheral blood samples were obtained after informed consent.
T cell purification and proliferation assays T cell proliferation assays were
performed in RPMI 1640 complemented with 2 mM glutamine, 1 mM sodium
pyruvate, 1% nonessential amino acids, 0.05 mM 2-mercaptoethanol, 100 U
penicillin per ml, 100 µg streptomycin per ml (all from Life Technologies,
Chagrin Falls, OH), and 5% pooled homologous plasma (complete medium).
Peripheral blood mononuclear cells (PBMC) were separated by centrifugation
over Ficoll-Hypaque (Lymphoprep, Nycomed-Pharma, Oslo, Norway) and left
to adhere (6 3 106cells per ml) in Petri dishes for 2 h at 37°C in complete
medium. After extensive washing, adherent cells were incubated for 30 min in
0.2% ethylenediamine tetraacetic acid, removed from dishes by scraping, X-
irradiated, and then used as antigen presenting cells (APC) at 105 cells per well.
The nonadherent fraction was depleted of CD191, HLA-DR1, and CD41 or
CD81 cells by incubation with immunomagnetic beads coated with specific
monoclonal antibodies (MoAb) (Dynabeads M450, Dynal, Oslo, Norway).
After two rounds of bead depletion, .98% pure CD81 or .95% pure CD41
T cells were obtained, as confirmed by flow cytometry analysis. In selected
experiments, CD41 T cells were further purified into CD45RA1 and
Table I. Characteristics of the subjects included in the study and results of purified CD4F and CD8F T cell proliferation to
NiSO4 in vitro
a
CD41 T cells CD81 T cells
Patch test
Subjects Sex Age ACD to Ni reactivity – NiSO4 – NiSO4
1. GC F 31 1 1111 1.70 6 0.38 30.24 6 2.80 1.24 6 0.16 16.49 6 1.97
2. DS F 26 1 111 1.18 6 0.39 34.48 6 1.68 0.71 6 0.04 5.26 6 0.14
3. PL F 32 1 11 3.44 6 1.92 45.79 6 6.19 1.25 6 0.07 12.62 6 0.15
4. DPE F 22 1 111 2.40 6 0.17 29.47 6 1.82 1.58 6 0.32 4.23 6 0.89
5. SL F 31 1 111 2.20 6 0.42 50.24 6 0.88 3.50 6 0.38 8.91 6 0.01
6. EG F 36 1 1 4.14 6 0.23 41.21 6 1.49 1.46 6 0.24 6.72 6 0.36
7. PT F 32 1 111 2.18 6 0.05 31.73 6 0.51 0.80 6 0.51 9.97 6 1.21
8. SP F 29 1 1 1.40 6 0.20 8.91 6 0.44 2.07 6 0.74 7.99 6 1.20
9. AC M 34 1 11 4.39 6 0.38 44.71 6 1.10 2.98 6 0.79 19.88 6 3.10
10. RAM F 31 1 111 2.31 6 0.37 15.52 6 1.61 2.84 6 0.26 9.93 6 0.86
1. CA F 32 – – 0.54 6 0.11 3.57 6 0.17 3.28 6 0.01 3.65 6 0.36
2. GG M 39 – – 0.70 6 0.34 21.15 6 0.29 2.57 6 0.19 2.60 6 0.86
3. DM F 24 – – 2.77 6 0.14 81.91 6 7.34 3.37 6 1.10 3.41 6 0.92
4. DC M 39 – – 0.51 6 0.10 13.89 6 3.39 3.38 6 1.21 3.25 6 0.41
5. GZ F 39 – – 1.83 6 0.21 46.13 6 4.98 1.80 6 0.21 2.50 6 0.43
6. SC F 28 – – 3.93 6 0.47 29.33 6 3.40 4.12 6 0.76 5.73 6 0.12
7. MP F 27 – – 3.01 6 0.91 13.25 6 3.51 1.04 6 0.15 1.84 6 0.15
8. MLP M 31 – – 1.06 6 0.42 6.65 6 1.56 0.32 6 0.02 0.73 6 0.01
9. PLC M 29 – – 0.75 6 0.15 22.49 6 6.22 0.58 6 0.09 0.94 6 0.06
10. FN F 24 – – 0.84 6 0.07 9.62 6 0.10 0.19 6 0.034 0.25 6 0.01
aCD41 and CD81 T cells were purified from nonadherent PBMC by immunomagnetic depletion with specific MoAb, and used as responder cells (1.5 3 105 cells per well) in a
proliferation assay together with peripheral blood adherent cells (105 cells per well) as APC, in the absence or in the presence of the optimal NiSO4 concentration (12–24 µg per ml).
[3H]Thymidine incorporation was measured after 5 d of culture. Results are given as mean cpm 3 103 6 SD of triplicate cultures.
CD45RO1 T cells by negative selection. To this end, purified CD41 T cells
were incubated with anti-CD45RO (UCHL-1) or anti-CD45RA (L48) MoAb
(Becton Dickinson, San Jose, CA) for 1 h at 4°C, followed by anti-mouse IgG-
conjugated immunomagnetic beads. Purified T cell populations were used as
Figure 1. Ni-specific CD4F T cells from allergic and nonallergic
individuals proliferates in vitro to NiSO4, whereas only allergic patients
show Ni-specific CD8F T cell responses. CD41 T cells (A, from allergic
patients; B, from nonallergic individuals) and CD81 T cells (C, from allergic;
D, from nonallergic) were purified from peripheral blood by negative selection
with immunomagnetic beads, and used as responders (1.5 3 105 cells per well)
in proliferation assay together with autologous adherent cells (105 cells per
well). Results are shown as stimulation index, which represents the ratio
between the mean [3H]thymidine incorporation of triplicate cultures tested in
the presence and in the absence of NiSO4. Differences in CD4
1 T cell
proliferation between allergic and nonallergic subjects were not significant
(p . 0.05) at each NiSO4 concentration.
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responder cells in proliferation assays performed in triplicate at 1.5 3 105 cells
per well in flat-bottom 96 well plates without or with 0.6–24 µg NiSO4 per ml
(Sigma, St. Louis, MO). After 5 d, cocultures were pulsed with 5 µCi
[3H]thymidine per ml (Amersham, Little Chalfont, U.K.) for about 16 h at
37°C, and then harvested onto fiber coated 96 well plates (Packard Instruments,
Groningen, The Netherlands). Radioactivity was measured in a beta counter
(Topcount, Packard Instruments). Results are given as the stimulation index,
which represents the ratio of [3H]thymidine uptake in the presence and the
absence of NiSO4. MHC restriction of CD4
1 and CD81 T cell reactivity to
NiSO4 was evaluated by incubating APC with 10 µg per ml of pooled anti-
Figure 2. Both allergic patients and nonallergic subjects harbor Ni-
specific memory CD4F CD45ROF T lymphocytes. CD41 T cells were
purified by indirect immunomagnetic separation using UCHL-1 and L48
MoAb, and then used in proliferation assay. (A) Representative CD41 T cell
staining before (left panel) and after (middle and right panels) purification. Cells
were labeled with fluorescein isothyocyanate-conjugated anti-CD45RA and
phycoerythrin-conjugated anti-CD45RO. (B) Proliferative response of
CD41CD45RO1 and CD41CD45RA1 T cell subsets from six nonallergic
and six allergic individuals in the presence of 12 µg NiSO4 per ml using
adherent cells as APC.
Table II. Allergic patients and nonallergic individuals show similar frequency of Ni-specific CD4F T lymphocytes, but differ in
the frequency of Ni-responsive CD8F T lymphocytes
Frequency of Ni-specific T cells Frequency of Ni-specific T cells
Allergic CD41 CD81 Nonallergic CD41 CD81
1. GC 1:2669 1:2660 1. DM 1:2439 1:80402
2. RAM 1:2841 1:25988 2. SC 1:1697 1:107555
3. SL 1:3440 1:31149 3. MP 1:7446 NCa
4. DS 1:2756 1:17278 4. PLC 1:6216 1:45817
5. PT 1:5434 1:24933 5. GG 1:2669 NC
6. EG 1:4220 1:19734 6. DC 1:4250 NC
mean 1:3560 1:20290 mean 1:4119 NDb
aNC, not calculable.
bND, not determined.
HLA-DR, -DP, and -DQ MoAb, anti-HLA class I MoAb, or mouse IgG (all
from Becton Dickinson) for 30 min at 4°C and then for additional 30 min at
37°C prior to their use in proliferation assays.
Frequency of Ni-specific T cells Frequency of Ni-specific T cells was
assessed by limiting dilution of purified CD41 and CD81 T cells (500–20,000
cells per well) in the presence of 6 µg NiSO4 per ml and 104 irradiated
autologous PBMC in U-bottomed 96 microplates in complete medium. For
each dilution, 24 replicate cultures in the presence of NiSO4 were compared
with 12 replicate cultures performed in the absence of NiSO4. [
3H]Thymidine
incorporation was measured after 5 d of culture. Ni-stimulated cultures in
which the cpm exceeded the mean cpm plus 3 SD of the 12 corresponding
antigen-free cultures were considered as positive. The distribution of Ni-
reactive T cells was analyzed by plotting the fraction of the nonresponding
cultures on the y axis and the cell input on the x axis. The frequency of Ni-
specific T cells could be roughly calculated as the inverse of the number of
T cells giving rise to 37% negative wells, as described by Lefkovitz and
Waldman (1979).
T cell cloning, immunophenotype, cytokine production CD41 and
CD81 short-term T cell lines were cloned by limiting dilution in the presence
Figure 3. Frequency of Ni-specific CD4F and CD8F T cells. Results of
the limiting dilution assays performed with purified CD41 and CD81 T cells
from six allergic (A, CD41; C, CD81) and six nonallergic individuals (B,
CD41; D, CD81). T cells (500–20,000 cells per well) were plated with 104
irradiated adherent PBMC in U-bottomed microplates in the presence of 6 µg
NiSO4 per ml, and evaluated for [
3H]thymidine uptake as described in Materials
and Methods. For each Ni concentration, 24 replicates in the presence of NiSO4
and 12 without NiSO4 were plated. Wells showing [
3H]thymidine incorporation
exceeding the mean 6 3 SD of the controls were considered positive. The
estimated frequencies roughly correspond to the condition showing 37% of
negative replicates, and are shown in Table II.
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Figure 4. Ni-specific CD4F T cell clones from allergic patients and
nonallergic individuals display a distinct pattern of cytokine release.
Culture supernatants were collected 48 h after stimulation with 10 ng PMA
per ml and 1 µg ionomycin per ml, and content of IFN-γ (A), IL-4 (B), and
IL-10 (C) was measured by enzyme-linked immunosorbent assay. Ni-specific
T cell clones from nonallergic donors (n 5 50) released a lower amount of
IFN-γ (p 5 0.03) and higher IL-10 (p 5 0.006), compared with T cell clones
from allergic patients (n 5 50). No significant differences were observed for
IL-4 release.
of 2 3 105 PBMC, 20 U rIL-2 per ml (kindly provided by Chiron Italia) and
1% phytohemagglutinin (Life Technologies) in U-bottomed 96 well microplates
in complete medium containing 10% fetal bovine serum (Hyclone, Logan,
UT). Clones were grown with rIL-2 (20 U per ml) and stimulated once a
month with 1% phytohemagglutinin in the presence of feeder cells. Antigen
specificity of T cell clones was assessed using autologous EBV-transformed B
cell lines or PBMC as APC and 12 µg NiSO4 per ml. Immunophenoytpe of
the clones was evaluated by double-color flow cytometry analysis using anti-
CD4, anti-CD8, anti-TCRαβ, and anti-TCRγδ fluorescein isothyocyanate-
or phycoerythrin-conjugated MoAb (Becton Dickinson). CLA expression was
studied using the HECA-452 MoAb (kindly provided by Dr. Louis J. Picker,
Laboratory of Experimental Pathology, Department of Pathology, University
of Texas South-western Medical Center, Dallas, TX) or control rat IgM,
followed by phycoerythrin-conjugated anti-rat IgM (Pharmingen, San Diego,
CA). Cells were analyzed with a FACScan equipped with Cell Quest software
(Becton Dickinson, Mountain View, CA). Supernatants from T cell clones (106
cells per ml) stimulated in 24 wells with 10 ng phorbol 12-myristate 13-acetate
(PMA) per ml and 1 µg ionomycin per ml (Sigma), or with NiSO4 (12 µg
per ml) plus 106 autologous irradiated PBMC, were collected after 24–48 h
culture, filtered, and stored at –80°C. IL-2, IL-4, IL-10, and IFN-γ content was
measured by enzyme-linked immunosorbent assay (R&D Systems, Minneapolis,
MN), following the manufacturer’s instructions.
Statistical analysis Data were compared using the Mann–Whitney rank sum
test (SigmaStat, Jandel, San Rafael, CA); p values ø 0.05 were considered signi-
ficant.
RESULTS
CD4F T cells from both allergic patients and healthy controls
proliferate in vitro in response to NiSO4 Patients included in our
study had a positive history of eczematous dermatitis after contacting
metals and a positive patch test to 5% NiSO4 (Table I). Nonallergic
individuals had no history of dermatitis to metals and a negative patch
test to NiSO4 even after pretreatment of the skin with 0.1% sodium
lauryl sulfate, a procedure that increases the sensitivity of the patch test
(Seidenari et al, 1996). Neither the patients nor the healthy individuals
had personal or family history of atopic diseases, and serum IgE were
within normal limits. To assess the Ni-specific T cell response to
NiSO4, pure CD4
1 T cell populations prepared from Ni-allergic and
nonallergic subjects were compared in proliferation assays in the
presence of autologous adherent cells and serial dilution of NiSO4. As
shown in Table I and Fig 1, both allergic and nonallergic displayed a
strong CD41 T cell proliferation to NiSO4, without significant
differences at each NiSO4 concentration tested. NiSO4 concentrations
above 24 µg per ml were toxic, and drastically reduced T cell
proliferation. CD41 T cell responses to Ni were markedly inhibited
by blocking MHC class II receptors on APC with pooled anti-HLA-
DR, -DP, and -DQ MoAb, but not with mouse IgG or anti-class I
MoAb (not shown). Among nonallergic and allergic donors, both high
and low responders were identified, without correlation either with
the severity of the disease or with the patch test reactivity in the latter
individual group (Table I). Peripheral blood samples were obtained
either prior to or 2 wk after patch testing, but patch testing did not
influence per se the magnitude of the CD41 T cell responses, as no
significant differences in the extent of the Ni-specific T cell proliferation
were observed between assays performed before and after patch testing
(not shown).
The CD45ROF memory T cell subset mainly accounts for
CD4F T cell proliferation to NiSO4 To exclude the possibility
that the CD41 T cell responses observed in nonallergic subjects could
have depended on in vitro T cell priming, CD41 T cell proliferation
to NiSO4 was examined using purified CD45RO
1 CD45RA– (mem-
ory) and CD45RA1 CD45RO– (naı¨ve) subsets as responders. Separa-
tion of CD45RO1 and CD45RA1 cells was performed by negative
selection using an indirect immunomagnetic technique with L48
and UCHL-1 MoAb, respectively, followed by anti-IgG-conjugated
magnetic beads, and purification was assessed by two-color fluores-
cence-activated cell sorter analysis (Fig 2A). Indeed, CD41 CD45RO1
T cells from nonallergic individuals proliferated significantly to NiSO4,
demonstrating the presence of Ni-specific CD41 memory T cells in
nonallergic individuals (Fig 2B). A similar pattern of CD41 T cell
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Table III. Ni-specific CD4F T cell clones from both allergic and nonallergic individuals display a similar pattern of cytokine
release in response to different stimulia
PMA 1 ionomycin APC 1 NiSO4
T cell clones IFN-γ IL-4 IL-10 IFN-γ IL-4 IL-10
DM35b Th1 7776 2 530 3581 1.4 376
DM44b – 32 0.7 2817 30 0.5 2120
SC1b Th1/Th0 8000 2100 310 5240 1900 230
SC21b – 250 0 3800 240 0 2450
MLP8b Th1 3900 0 0 3850 0 0
GC20c Th1 3300 0 0 1720 42 0
GC34c Th1 2000 71 0 2091 21 0
AC29c – 108 1.4 3046 30 7 1211
AC60c Th1 10100 0 0 5712 0 0
PL45c Th1 3500 400 1500 2801 311 982
aCulture supernatants were collected 48 h after stimulation with 10 ng PMA per ml and 1 µg ionomycin per ml, or autologous APC and 12 µg per ml NiSO4. IFN-γ, IL-4, and IL-
10 were measured by enzyme-linked immunosorbent assay. Data are expressed as pg per ml.
bNi-specific CD41 T cell clones from nonallergic individuals.
cNi-specific CD41 T cell clones from allergic patients.
responses were observed in allergic patients. CD41 CD45RA1 T cells
from both allergic and nonallergic individuals proliferated to NiSO4
as well, although to a lesser extent. When CD41CD45RO1 and
CD41CD45RA1 T cells from the same subjects where tested with
the recall antigen, tetanus toxoid, a strong proliferative response of
CD41CD45RO1 T cells and a much lower, but still significant,
proliferation of CD41CD45RA1 T cells were observed (not shown).
It has recently been demonstrated that in the absence of antigenic
stimulation memory T cells may reacquire an unprimed (CD45RA1
CD45RO–) phenotype, suggesting that the CD45RA/CD45RO
switch is not unidirectional (Rothstein et al, 1991; Hamann et al,
1996). Therefore, it is possible that the Ni-specific proliferation of
CD41 CD45RA1 T cells may depend on reversal of CD45 isoform
switching of resting Ni-specific T cells rather than on in vitro T
cell priming.
CD8F T cells from Ni-allergic patients, but not from healthy
individuals, proliferate in vitro in response to NiSO4 CD8
1 T
cells are thought to be critical in the development of murine CH
(Gocinski and Tigelaar, 1990; Bour et al, 1995; Xu et al, 1996). Hapten-
specific CD81 T cell clones have been isolated from patients with
ACD to urushiol (Kalish and Johnson, 1990), and, more recently, from
patients with ACD to Ni (Vollmer et al, 1997; Werfel et al, 1997),
suggesting their contribution to the expression of the human disease
as well. Thus, purified CD81 T cells obtained from both allergic and
nonallergic individuals were compared in terms of proliferation to
NiSO4. Results showed that CD8
1 T cells from all allergic individuals
proliferated to Ni (stimulation index . 3), whereas nonallergic subjects
failed to respond to the hapten (Fig 1, Table I), suggesting that the
presence of Ni-specific CD81 T cells is required for the expression of
the disease.
The frequency of Ni-specific CD4F T cells is comparable in
allergic and nonallergic subjects, whereas the frequency of
CD8F T cells is higher in patients The frequency of peripheral
blood derived Ni-specific T cells was determined by limiting dilution
analysis. In agreement with the proliferation data, the estimated
frequency of Ni-specific CD41 T cells from allergic and nonallergic
individuals did not show significant differences, ranging in both subject
groups from 1:1700 to 1:6200. In contrast, the frequency of Ni-specific
CD81 T cells ranged from 1:2600 to 1:31,000 in allergic patients, and
was extremely low or undetectable in nonallergic subjects (Fig 3,
Table II).
Ni-specific CD4F T cell clones derived from peripheral blood
of allergic and nonallergic individuals are both CLAF but
display a different pattern of IL-10 and IFN-g release In the
following experiments, a large number of Ni-specific T cell clones
were prepared from peripheral blood of allergic patients and nonallergic
donors and compared for the pattern of cytokine release and CLA
expression. These clones were all CD41, CD8–, TCRαβ1, and
TCRγδ– (not shown). Ni-specific CD41 T cell clones (n 5 50) from
nonallergic individuals displayed lower IFN-γ (mean 3.56 vs 4.72 ng
per ml, p 5 0.03), and increased IL-10 release (1.04 vs 0.4 ng per ml,
p 5 0.006) when compared with T cell clones (n 5 50) prepared from
allergic patients, whereas IL-4 production did not differ significantly (0.4
vs 0.2 ng per ml, nonallergic and allergic, respectively) (Fig 4).
Comparing the resulting pattern of cytokine release, CD41 clones
from nonallergic individuals showed a lower percentage of Th1 clones
(58% vs 76%) and a similar number of Th0 clones (26% vs 24%),
whereas only 4% of T cell clones from nonallergic subjects, and none
from allergic subjects, showed a clear cut Th2 pattern. Interestingly
enough, IL-10 was the predominant cytokine produced by 15 of 50
(30%) and by three of 50 (6%) of the Ni-specific CD41 T cell clones
isolated from nonallergic and allergic individuals, respectively. These
T cell clones exhibited high IL-10 production and very low or
undetectable IFN-γ or IL-4 release, and could not fulfil the criteria
for the Th1 or Th2 pattern. Representative IL-10high producing T cell
clones are shown in Table III. In the remaining T cell clones from
both individual groups, IL-10 release did not segregate with IFN-γ or
IL-4 production, and was detected in either Th2, Th0, as well as Th1
subsets, as previously reported (Del Prete et al, 1993). The same pattern
of cytokine release was observed when T cell clones were stimulated
with PMA and ionomycin or autologous APC and NiSO4, although
lower amounts of cytokines were released with the latter stimulation
(Table III).
CLA is thought to be the major homing receptor for T cell targeting
to the skin, being selectively expressed on the majority of skin-
infiltrating T cells during ACD (Picker et al, 1991; Bos et al, 1993;
Santamaria Babi et al, 1995). Therefore, differences in the CLA
expression on Ni-specific T cells could be crucial in determining the
clinical outcome of the immune response to the hapten. Figure 5
shows that the large majority of Ni-specific CD41 T cell clones
prepared from peripheral blood of both allergic and nonallergic donors
were CLA1, thus possessing the potential for recirculating through
the skin.
Ni-specific CD8F T cell clones from allergic individuals express
a Tc1 phenotype and are CLAF To better characterize the Ni-
specific CD81 T cell responses, 20 Ni-specific CD81 T cell clones
(CD81, CD4–, TCRαβ1, and TCRγδ–) isolated from five allergic
patients were examined for cytokine release and nine of them for CLA
expression. Results indicated that the great majority of hapten-specific
CD81 T cell clones were CLA1 and produced IFN-γ but not IL-4,
thus belonging to the Tc1 subset (Fig 6). Several attempts to isolate
CD81 T cell clones from nonallergic subjects failed, in agreement
with their very low frequency in these individuals.
DISCUSSION
In murine models, it has been demonstrated that the expression of CH
to haptens is primarily regulated through the activities of distinct T
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Figure 5. Ni-specific CD4F T cell clones from both allergic and
nonallergic individuals express the CLA skin homing receptor. T cell
clones were stained with rat IgM (white bars) or HECA-452 MoAb (black bars)
followed by phycoerythrin-conjugated anti-rat IgM, and examined by flow
cytometry. Results are shown as mean fluorescence intensity.
cell subsets. Using CD41- or CD81-Ab-depleted mice (Gocinski and
Tigelaar, 1990) and MHC class II or class I knockout mice (Bour et al,
1995), it has been shown that hapten-specific IFN-γ-producing CD81
T cells are crucial for the development of CH and exert a major
effector function. In contrast, CD41 T cells appear to perform a
predominant regulatory activity by releasing type 2 cytokines and IL-
10 (Xu et al, 1996). So far no studies have compared the reciprocal
role of CD41 and CD81 T cells in human disease, but indirect
evidence suggests an important role for CD81 T cells in the cutaneous
reactions to haptens. In particular, ACD to Ni has been documented
in patients with CD41 idiopathic lymphopenia (Goodrich et al, 1993)
and in HIV1 patients with very low CD41 T cell counts (Viraben
et al, 1994). Moreover, hapten-specific CD81 T cells have been isolated
Figure 6. Ni-specific CD8F T cell clones from Ni-allergic patients are
CLAF and belong to the Tc1 subset. (A) CLA expression was evaluated as
described in Fig 5. (B) Cytokine release was measured by enzyme-linked
immunosorbent assay in culture supernatants 48 h after stimulation with PMA
and ionomycin.
from peripheral blood of patients with ACD to urushiol, a strong
sensitizer contained in poison ivy (Kalish and Johnson, 1990), and,
more recently, from the peripheral blood and the skin of patients with
ACD to Ni (Vollmer et al, 1997; Werfel et al, 1997).
Ni is a widely diffused metal and it is the most common cause of
ACD (Peltonen, 1979); however, in spite of the large diffusion of the
hapten and the extremely high possibility of contacting Ni-releasing
materials in professional settings and in everyday life, most people are
apparently protected from the development of ACD to Ni. To assess
whether the expression of the disease could be related to the expansion
of distinct T cell subsets and/or a different pattern of cytokine release,
we compared the characteristics of Ni-specific T cell responses in Ni-
allergic patients and in nonallergic, healthy individuals. Our results
showed that Ni-specific CD81 T cell responses could be detected
only in allergic patients. Ni-specific CD81 T cell clones prepared from
these patients displayed a Tc1 pattern of cytokine release and were
CLA1, suggesting their active intervention in the expression of the
dermatitis. The lack of functional CD81 T cell responses in nonallergic
individuals could have different explanations. First, it might be the
consequence of a reduced capacity to generate MHC class I-restricted
hapten-epitopes. Because haptens recognition by CD81 T cells depends
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on the interaction of the chemical with MHC class I-loaded peptides
(Martin et al, 1992), a different repertoire of bound peptides could
greatly influence the generation of appropriate numbers of antigenic
stimuli. Ni-allergy, however, has not been definitely associated with
particular HLA class II or class I alleles (Emtestam et al, 1993).
Alternatively, the expansion of effector CD81 T cells might be
prevented by regulatory mechanisms, including hapten-specific sup-
pressor T cells. In contrast to CD81 T cell responses, both allergic
and nonallergic individuals were shown to harbor in the peripheral
blood Ni-specific CD41 T cells belonging to the CD45RO1 memory
subset. Both the frequency of Ni-specific CD41 T cells and the
magnitude of the Ni-specific CD41 T cell responses to different
NiSO4 concentrations were similar in allergic and nonallergic subjects.
These findings suggest that CD41 T cell priming to Ni occurs also in
nonallergic subjects, and can be related to the continuous exposure to
this ubiquitous metal. In keeping with our results, it has been shown
that T cell responses to Dermatophagoides farinae and Parietaria judaica
can be detected in both allergic and nonallergic subjects (Cavaillon
et al, 1988; Sallusto et al, 1993). In such a case, the expression of the
allergic disease has been related to the cytokine pattern of allergen-
specific CD41 T cells that were shown to belong to the Th2 subset
in atopic individuals and to the Th1 subset in healthy subjects (Wierenga
et al, 1991).
Our results showed that the great majority of Ni-specific CD41 T
cells form both allergic and nonallergic subjects were CLA1 and thus
they do not differ in their capacity to target to the skin. In contrast, a
distinct pattern of cytokine release was observed. Ni-specific CD41 T
cell clones from nonallergic subjects exhibited lower IFN-γ production
and augmented IL-10 release compared with T cell clones from allergic
patients. In contrast to our data, no differences in IFN-γ production
were observed by Kapsenberg et al (1992) when Ni-specific T cell
clones obtained from two allergic patients and from a single nonallergic
donor were compared. In 15 of 50 (30%) Ni-specific CD41 T cell
clones obtained from nonallergic individuals, and in three of 50 (6%)
clones from patients with ACD to Ni, a unique pattern of cytokine
release was detected, consisting of high IL-10 and low or undetectable
IFN-γ, IL-4, and IL-2 release. These IL-10high Ni-reactive CD41 T
cell clones closely resembled a newly identified CD41 T cell subset,
named T regulatory cells 1 (Tr1), generated in vitro in the presence of
IL-10 from both human peripheral blood and murine spleen cells. Tr1
cells produce a high amount of IL-10 and low quantities of IL-2, IL-
4, and IFN-γ, and display an immunosuppressive function both in vitro
and in vivo (Groux et al, 1997). Work is currently in progress in our
laboratory to better define the functional role of these Ni-specific IL-
10high T cell clones. In humans, IL-10 has been identified as a potent
anti-inflammatory cytokine produced by both Th1 and Th2 CD41 T
cell clones (Del Prete et al, 1993), which inhibits T cell proliferation
of both subsets, and regulates the development of Th1 cells by
blocking IL-12 driven Th1 responses (D’Andrea et al, 1993). The
immunosuppressive effects of IL-10 mostly depend on the inhibitory
activity on the APC functions of dendritic cells and macrophages
(Fiorentino et al, 1991; Enk et al, 1993; Hsieh et al, 1993). Strong
evidence exists demonstrating that IL-10 provides fundamental regu-
latory mechanisms for both the induction and the effector phases of
murine CH. IL-10 mRNA is enhanced in the skin of allergic patients
challenged with NiSO4 (Szepietowski et al, 1997) as well as in the skin
of sensitized mice challenged with the relevant hapten (Ferguson et al,
1994). Neutralization of IL-10 with local injections of specific MoAb
prolongs murine CH beyond its natural course (Ferguson et al, 1994);
IL-10 injection during the sensitization process or before challenge
with the hapten markedly decreases CH responses, and induces hapten-
specific unresponsiveness (Enk et al, 1994). Finally, CH to haptens is
enhanced in mice with targeted disruption of the IL-10 gene (Berg
et al, 1995). Whether Ni-specific IL-10 producing CD41 T cells could
have a direct role in preventing clinical expression of ACD, e.g., by
downregulating Ni-specific CD81 responses, needs to be further
investigated. In keeping with this hypothesis, it has been shown that
IL-10 inhibits murine as well human CD81 T cell proliferation and
IFN-γ production (Bejarano et al, 1992; Macatonia et al, 1993). Also
IL-4 has been described as an important regulatory cytokine in murine
CH (Gautam et al, 1992; Asada et al, 1997), but other experiments
using IL-4 knockout mice have produced contrasting data, with CH
reactions either depressed (Weigmann et al, 1997) or similar (Berg et al,
1995) when compared with CH reactions in littermate controls. Finally,
it has been shown that skin infiltrating Ni-specific CD41 T cells
produced higher amount of IL-4 than Ni-specific T cell clones derived
from peripheral blood (Werfel et al, 1997). Although we could not
detect significant differences in IL-4 production between Ni-specific
CD41 T cell clones from allergic and nonallergic individuals, we
cannot exclude a contribution of IL-4 in the modulation of ACD.
In conclusion, our results indicate that the expansion of Ni-specific
CD81 T cells is directly correlated to the expression of ACD to Ni,
whereas Ni-specific CD41 T cells may have a predominant regulatory
function, possibly via release of IL-10. Strategies to selectively target
these distinct T cell populations should prove to be helpful in
immunotherapeutic approaches to ACD.
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